Centre of Excellence in Nutraceuticals inaugurated by the Hon’ble Chief Minister of Kerala

T’puram: Chief minister Pinarayi Vijayan virtually inaugurated a centre of excellence in nutraceuticals (CoEN) at Bio 360 Life Sciences Park, Thonnakkal, on Monday.

The initiative, spearheaded by Kerala State Council for Science, Technology and Environment (KSCSTE), with support from Kerala Development and Innovation Strategic Council (K-DISC) and Kerala State Industrial Development Corporation (KSIDC) and financial assistance from KIIFB, aims to position state as a leading hub for research and innovation in the rapidly expanding nutraceutical sector.

In his address, Vijayan highlighted the growing global relevance of nutraceuticals in addressing modern health challenges. “Bioactive compounds derived from food play an important role in enhancing immunity, preventing diseases and managing chronic conditions. The establishment of a centre of excellence in nutraceuticals marks a significant milestone in Kerala’s efforts to advance science-based preventive healthcare,” he said.

The centre began functioning at the campus of Institute of Advanced Virology (IAV) within Bio 360 Life Sciences Park and was allotted 5 acres for developing its dedicated infrastructure. The project will be implemented in phases, with Rs 13.99 crore sanctioned by KIIFB over a 5-year period.

Presenting the institutional roadmap, E Sreekumar, chief executive officer of CoEN, said Phase 1 will focus on research, technology development and scientific validation of nutraceutical formulations, particularly in areas related to metabolic health and wellness. Phase 2 will establish an enterprise division to facilitate manufacturing, technology transfer and commercialisation of research outcomes in collaboration with industry.

In the keynote address, C Anantharamakrishnan, director of CSIR–NIIST, hailed Kerala govt for its proactive initiatives in promoting science, research and innovation, noting that such efforts are crucial for strengthening the state’s emerging bioeconomy and nutraceutical sector.

Related Posts

Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

Mumbai: A promoter entity of Ajanta Pharma Ltd. on Tuesday offloaded a nearly 3% stake in the company through open market transactions, even as domestic institutional investors stepped in to absorb a large…

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

Pune: In a major crackdown against illegal pharmaceutical activities that compromise public health, the Food and Drug Administration (FDA) has seized a stock of medicines worth above Rs24.81 lakh from…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

ICMR-NIN study links micronutrient deficiencies to higher dementia risk

ICMR-NIN study links micronutrient deficiencies to higher dementia risk

Pvt nursing home sealed in Chatra after woman, unborn baby die

Pvt nursing home sealed in Chatra after woman, unborn baby die

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy